Start with what you need treated.

Immunotherapy works by boosting or restoring the body's natural immune response against cancer cells, using medications such as checkpoint inhibitors that block proteins cancer cells use to evade immune detection, allowing the immune system to recognize and destroy the cancer more effectively. This approach has transformed treatment for many cancer types, including melanoma, lung cancer, kidney cancer, and certain lymphomas, often providing significant and sometimes remarkably durable responses in appropriately selected patients. Treatment is typically administered through an intravenous infusion in an outpatient clinic setting, with sessions usually every two to six weeks depending on the specific medication, and each session generally taking 30 minutes to a couple of hours. Because immunotherapy works by activating the immune system, it carries a distinct side effect profile compared to traditional chemotherapy, including the possibility of the immune system attacking healthy tissue, which requires close monitoring and prompt management if it occurs. Regular blood tests and imaging track both treatment response and monitor for any immune-related side effects throughout the course of treatment. Many patients experience good tolerance of treatment with meaningful, sometimes long-lasting, cancer control.

Invasive lobular carcinoma treatment follows similar principles to other breast cancer treatment but requires special consideration of this subtype's tendency to grow in a diffuse, single-file pattern that can make it harder to detect on standard imaging and to achieve clear surgical margins, sometimes requiring more extensive pre-operative imaging such as MRI to accurately assess the extent of disease. Surgical options range from breast conservation surgery (lumpectomy) to mastectomy, chosen based on tumor extent and patient preference, performed under general anesthesia. Since this cancer type is very commonly hormone-receptor positive, hormonal therapy is a key component of treatment for most patients, taken as a daily oral medication for five to ten years after initial treatment to reduce recurrence risk. Radiation therapy is typically recommended following breast conservation surgery, delivered over several weeks on an outpatient basis. A multidisciplinary team tailors the overall treatment plan based on the tumor's specific size, grade, and hormone receptor status. Regular long-term follow-up monitors for recurrence, which for this subtype can sometimes occur many years after initial treatment.

Kaposi sarcoma treatment depends significantly on the underlying cause and extent of disease, since this cancer is strongly associated with immunosuppression, particularly in patients with HIV/AIDS or those on immunosuppressive medication after organ transplant, and improving the underlying immune function is often a critical part of treatment. For limited skin lesions, local treatments such as targeted radiation, cryotherapy, or topical medication can be effective, while more widespread disease affecting internal organs typically requires systemic chemotherapy. In HIV-associated Kaposi sarcoma, effective antiretroviral therapy to control the underlying HIV infection is fundamental to treatment and can lead to significant improvement or even resolution of the cancer in some cases. Treatment is generally managed on an outpatient basis, with the specific regimen and duration tailored to disease extent and response. Regular follow-up monitors both the cancer's response to treatment and the patient's underlying immune status. With appropriate, coordinated treatment addressing both the cancer and any underlying immunosuppression, many patients achieve good disease control.

Laryngeal and hypopharyngeal cancer treatment is carefully planned to balance effective cancer control with preservation of voice and swallowing function whenever possible, since these structures are critical for basic quality of life. Early-stage cancers can sometimes be treated with radiation therapy alone or minimally invasive surgery, aiming to preserve as much normal function as possible, while more advanced cancers typically require a combination of surgery, radiation, and chemotherapy, sometimes including more extensive surgery such as partial or total laryngectomy when the cancer is more advanced. Treatment decisions are made by a multidisciplinary team weighing the extent of disease against the functional impact of different treatment options. Surgery, when needed, is performed under general anesthesia with recovery time varying based on the extent of tissue removed and any reconstruction required. Speech and swallowing therapy is frequently an important part of both treatment planning and recovery, helping patients adapt and maximize functional outcomes. Regular follow-up monitors for cancer recurrence and manages any long-term effects of treatment on voice and swallowing.

Medullary thyroid carcinoma is treated primarily with total thyroidectomy, complete surgical removal of the thyroid gland, along with careful evaluation and often removal of nearby lymph nodes, since this cancer type has a higher tendency to spread to lymph nodes compared to more common thyroid cancer types. Because medullary thyroid carcinoma can be hereditary in a significant proportion of cases, associated with genetic syndromes such as multiple endocrine neoplasia, genetic counseling and testing are often recommended for both the patient and their family members following diagnosis. Blood levels of calcitonin and carcinoembryonic antigen, hormones and markers produced by this specific cancer type, are useful both before surgery to assess disease extent and after surgery to monitor for any recurrence. The surgery is performed under general anesthesia and typically takes two to three hours. Patients require lifelong thyroid hormone replacement medication following total thyroidectomy. Regular long-term follow-up with blood marker testing and imaging monitors for recurrence, which can sometimes occur even years after initial successful treatment.

Ovulation induction treats infertility caused by irregular or absent ovulation, using medications ranging from oral tablets like clomiphene citrate or letrozole for milder cases, to injectable hormone medications for more significant ovulation disorders, aimed at stimulating the ovaries to develop and release one or more mature eggs. Treatment is closely monitored through regular blood tests to check hormone levels and ultrasounds to track the growth of developing follicles, allowing the doctor to time intercourse or additional fertility procedures, such as intrauterine insemination, appropriately around the expected time of ovulation. The entire process, from starting medication to ovulation, typically spans about two to three weeks per cycle, conducted entirely on an outpatient basis with several monitoring visits. Close monitoring also helps identify and manage the risk of multiple pregnancy or ovarian hyperstimulation, particularly with injectable medications. Many women achieve successful ovulation and pregnancy with this relatively straightforward and lower-cost fertility treatment approach, though some may require several cycles or progression to more advanced fertility treatments if unsuccessful.

Pancreatic cancer treatment depends heavily on whether the tumor is deemed resectable, meaning it can potentially be completely removed surgically, since this significantly impacts prognosis and treatment approach. For resectable tumors, surgery, most commonly the Whipple procedure for tumors in the head of the pancreas, is performed under general anesthesia and is a major, technically demanding operation that can take four to eight hours, typically combined with chemotherapy given before or after surgery to address microscopic disease spread. For tumors that are locally advanced or have already spread beyond the pancreas at diagnosis, which unfortunately represents the majority of cases due to the disease often being detected late, treatment focuses on chemotherapy, sometimes combined with radiation therapy, aimed at controlling disease growth and managing symptoms. Recovery from pancreatic surgery is lengthy, given its complexity, with an extended hospital stay and gradual return to normal diet and activity over several weeks to months. A multidisciplinary team of surgical and medical oncologists, along with palliative care support when appropriate, coordinates the complex, individualized treatment plan and ongoing symptom management throughout the course of care.

Retinoblastoma treatment is carefully individualized based on the size and location of the tumor within the eye, whether one or both eyes are affected, and how far the disease has progressed, with a strong emphasis on preserving both life and vision whenever safely possible given that this cancer predominantly affects infants and young children. Smaller tumors may be treated with local therapies such as laser treatment or cryotherapy (freezing) to directly destroy the tumor, while larger tumors often require chemotherapy first to shrink the tumor before local treatment, an approach that has significantly improved the ability to preserve eyes and vision in recent years. For the most advanced cases affecting a single eye, or when vision cannot be preserved, surgical removal of the affected eye (enucleation) may be necessary to ensure the cancer does not spread further. Treatment is coordinated by a specialized pediatric ophthalmic oncology team, with treatment plans and hospital stay requirements varying considerably based on the specific approach needed. Because retinoblastoma can have a hereditary genetic basis, genetic counseling and testing are recommended for affected families. With modern treatment approaches, survival rates for retinoblastoma are excellent, particularly when the cancer is detected and treated early.

Robotic-assisted radical prostatectomy removes the entire prostate gland to treat localized prostate cancer, using a robotic surgical system that provides the surgeon with magnified, three-dimensional visualization and highly precise, wristed instrument movements through several small abdominal incisions, offering advantages in nerve preservation compared to traditional open surgery. The enhanced precision of the robotic approach can help the surgeon more carefully identify and preserve the delicate nerves responsible for erectile function that run alongside the prostate, when oncologically appropriate to do so. The procedure is performed under general anesthesia and typically takes two to three hours. Patients generally experience less blood loss, less pain, and a faster recovery compared to traditional open surgery, with most able to go home within a day or two. A urinary catheter remains in place for one to two weeks after surgery, with pelvic floor exercises recommended to help restore urinary control. Regular PSA monitoring after surgery tracks for any signs of cancer recurrence, with most patients with organ-confined disease achieving excellent long-term cancer control.

Skin cancer treatment most commonly involves surgical excision of the cancerous lesion along with an appropriate margin of surrounding healthy tissue to ensure complete removal, with the exact technique chosen based on the cancer type, size, and location. For basal cell and squamous cell carcinomas, standard excision or, for cancers in cosmetically or functionally sensitive areas, Mohs micrographic surgery, which allows precise, layer-by-layer removal while sparing as much healthy tissue as possible, are commonly used approaches. The procedure is typically performed under local anesthesia in an outpatient setting, taking 30 minutes to a couple of hours depending on the technique and extent of the cancer. The wound is then closed with sutures, or in some cases, a skin graft or flap is used for larger defects, particularly on the face. Most patients experience minimal downtime, with stitches typically removed within one to two weeks. When detected and treated early, the vast majority of common skin cancers are cured with surgical treatment alone, though regular skin checks are recommended afterward to monitor for new or recurrent lesions.

Testicular cancer treatment begins with surgical removal of the affected testicle (radical orchiectomy) through an incision in the groin, which serves both as the primary treatment and provides tissue for precise diagnosis of the specific cancer subtype, information that is crucial for guiding further treatment decisions. Depending on the cancer type, identified as either seminoma or non-seminoma, and the stage determined through imaging and blood tumor markers, further treatment may include a period of careful surveillance with regular monitoring, chemotherapy, or radiation therapy targeting the lymph nodes where this cancer commonly spreads. The initial surgery is performed under general or spinal anesthesia and typically takes 30 to 60 minutes, with most patients going home the same or next day. Additional treatment, when needed, is generally managed on an outpatient basis over subsequent weeks to months. Fertility preservation through sperm banking is often discussed and offered before treatment begins, particularly if chemotherapy or radiation is anticipated. Testicular cancer has one of the highest cure rates of any cancer type, even when it has spread beyond the testicle at diagnosis, with the vast majority of patients achieving long-term cure.

Thyroid cancer treatment typically begins with surgery, either removing the affected lobe of the thyroid (lobectomy) for smaller, lower-risk cancers, or removing the entire gland (total thyroidectomy) for larger tumors or higher-risk cancer features, often combined with removal of nearby lymph nodes if there is evidence of spread. The surgery is performed under general anesthesia through a small incision in the neck and typically takes one to three hours depending on the extent of thyroid removal required. For certain thyroid cancer types and stages, radioactive iodine therapy is given after surgery to destroy any remaining thyroid tissue or microscopic cancer cells, taken as a single oral dose followed by some temporary precautions around radiation exposure to others. Patients who have all or most of their thyroid removed require lifelong thyroid hormone replacement medication, with the dose carefully monitored through regular blood tests. Regular follow-up with blood tests and, when relevant, imaging monitors for any signs of cancer recurrence over subsequent years. The most common types of thyroid cancer, papillary and follicular, generally have an excellent prognosis with appropriate treatment.